Literature DB >> 32764141

Thematic Analysis of Hospice Mentions in the Health Records of Veterans with Advanced Kidney Disease.

Ann M O'Hare1,2, Catherine R Butler3, Janelle S Taylor4, Susan P Y Wong3,2, Elizabeth K Vig3,2, Ryan S Laundry2, Melissa W Wachterman5,6, Paul L Hebert2,7, Chuan-Fen Liu2,7, Nilka Rios-Burrows8, Claire A Richards2,9.   

Abstract

BACKGROUND: Patients with advanced kidney disease are less likely than many patients with other types of serious illness to enroll in hospice. Little is known about real-world clinical decision-making related to hospice for members of this population.
METHODS: We used a text search tool to conduct a thematic analysis of documentation pertaining to hospice in the electronic medical record system of the Department of Veterans Affairs, for a national sample of 1000 patients with advanced kidney disease between 2004 and 2014 who were followed until October 8, 2019.
RESULTS: Three dominant themes emerged from our qualitative analysis of the electronic medical records of 340 cohort members with notes containing hospice mentions: (1) hospice and usual care as antithetical care models: clinicians appeared to perceive a sharp demarcation between services that could be provided under hospice versus usual care and were often uncertain about hospice eligibility criteria. This could shape decision-making about hospice and dialysis and made it hard to individualize care; (2) hospice as a last resort: patients often were referred to hospice late in the course of illness and did not so much choose hospice as accept these services after all treatment options had been exhausted; and (3) care complexity: patients' complex care needs at the time of hospice referral could complicate transitions to hospice, stretch the limits of home hospice, and promote continued reliance on the acute care system.
CONCLUSIONS: Our findings underscore the need to improve transitions to hospice for patients with advanced kidney disease as they approach the end of life.
Copyright © 2020 by the American Society of Nephrology.

Entities:  

Keywords:  advanced kidney disease; concurrent care; concurrent dialysis; end-of-life; hospice; veteran

Mesh:

Year:  2020        PMID: 32764141      PMCID: PMC7608965          DOI: 10.1681/ASN.2020040473

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  25 in total

1.  Why don't patients enroll in hospice? Can we do anything about it?

Authors:  Elizabeth K Vig; Helene Starks; Janelle S Taylor; Elizabeth K Hopley; Kelly Fryer-Edwards
Journal:  J Gen Intern Med       Date:  2010-06-10       Impact factor: 5.128

2.  Discernment rather than decision-making among elderly dialysis patients.

Authors:  Ann J Russ; Sharon R Kaufman
Journal:  Semin Dial       Date:  2012 Jan-Feb       Impact factor: 3.455

3.  The value of "life at any cost": talk about stopping kidney dialysis.

Authors:  Ann J Russ; Janet K Shim; Sharon R Kaufman
Journal:  Soc Sci Med       Date:  2007-04-06       Impact factor: 4.634

4.  Family Perceptions of Quality of End-of-Life Care for Veterans with Advanced CKD.

Authors:  Claire A Richards; Chuan-Fen Liu; Paul L Hebert; Mary Ersek; Melissa W Wachterman; Lynn F Reinke; Leslie L Taylor; Ann M O'Hare
Journal:  Clin J Am Soc Nephrol       Date:  2019-08-29       Impact factor: 8.237

5.  Site of Death, Place of Care, and Health Care Transitions Among US Medicare Beneficiaries, 2000-2015.

Authors:  Joan M Teno; Pedro Gozalo; Amal N Trivedi; Jennifer Bunker; Julie Lima; Jessica Ogarek; Vincent Mor
Journal:  JAMA       Date:  2018-07-17       Impact factor: 56.272

6.  End-of-Life Care for Patients With Advanced Kidney Disease in the US Veterans Affairs Health Care System, 2000-2011.

Authors:  Susan P Y Wong; Margaret K Yu; Pamela K Green; Chuan-Fen Liu; Paul L Hebert; Ann M O'Hare
Journal:  Am J Kidney Dis       Date:  2018-01-10       Impact factor: 8.860

7.  Concurrent Hospice Care and Cancer-Directed Treatment for Advanced Lung Cancer and Receipt of Aggressive Care at the End of Life in the Veteran's Health Administration.

Authors:  Carolyn J Presley; Ling Han; John R O'Leary; Weiwei Zhu; Emily Corneau; Herta Chao; Tracy Shamas; Michal Rose; Karl Lorenz; Cari R Levy; Vincent Mor; Cary P Gross
Journal:  J Palliat Med       Date:  2020-03-02       Impact factor: 2.947

8.  The terrible choice: re-evaluating hospice eligibility criteria for cancer.

Authors:  David J Casarett; Jessica M Fishman; Hien L Lu; Peter J O'Dwyer; Frances K Barg; Mary D Naylor; David A Asch
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

9.  The rise of concurrent care for veterans with advanced cancer at the end of life.

Authors:  Vincent Mor; Nina R Joyce; Danielle L Coté; Risha A Gidwani; Mary Ersek; Cari R Levy; Katherine E Faricy-Anderson; Susan C Miller; Todd H Wagner; Bruce P Kinosian; Karl A Lorenz; Scott T Shreve
Journal:  Cancer       Date:  2015-12-15       Impact factor: 6.860

10.  Association of Family Ratings of Quality of End-of-Life Care With Stopping Dialysis Treatment and Receipt of Hospice Services.

Authors:  Claire A Richards; Paul L Hebert; Chuan-Fen Liu; Mary Ersek; Melissa W Wachterman; Leslie L Taylor; Lynn F Reinke; Ann M O'Hare
Journal:  JAMA Netw Open       Date:  2019-10-02
View more
  3 in total

1.  Concurrent Hospice and Dialysis: Proof of Concept.

Authors:  Catherine R Butler; Melissa W Wachterman; Ann M O'Hare
Journal:  J Am Soc Nephrol       Date:  2022-09-12       Impact factor: 14.978

2.  The Role of Dialysis Organizations in Promoting and Facilitating Access to Nondialytic Treatment Options.

Authors:  Catherine R Butler; Suzanne Watnick
Journal:  Kidney Med       Date:  2022-05-13

3.  Implications of Cross-System Use Among US Veterans With Advanced Kidney Disease in the Era of the MISSION Act: A Qualitative Study of Health Care Records.

Authors:  Ann M O'Hare; Catherine R Butler; Ryan J Laundry; Whitney Showalter; Jeffrey Todd-Stenberg; Pam Green; Paul L Hebert; Virginia Wang; Janelle S Taylor; Marieke Van Eijk; Kameron L Matthews; Susan T Crowley; Evan Carey
Journal:  JAMA Intern Med       Date:  2022-07-01       Impact factor: 44.409

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.